Laminin subunit alpha 2-related muscular dystrophy Advocacy Hub | UniteRare

At a Glance

Live from database

🔬

1Recruiting trials

🩺

7Specialists

Regulatory Watchboard

1 event

Oct 2023A 5-year Natural History Study in LAMA2-related Muscular Dystrophy and SELENON-related Myopathy.

Radboud University Medical Center — NA

TrialRECRUITING

Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Financial Assistance

FINANCIAL LANDSCAPE SUMMARY

Total programs

No financial assistance programs currently listed for Laminin subunit alpha 2-related muscular dystrophy.
Check the disease page for updates →

Clinical Trial Landscape

1 active trial

1N/A

1Total recruiting

Search clinical trials for Laminin subunit alpha 2-related muscular dystrophy →

Recent News & Research

No recent news articles indexed yet for Laminin subunit alpha 2-related muscular dystrophy.
Search PubMed for Laminin subunit alpha 2-related muscular dystrophy →

Browse all Laminin subunit alpha 2-related muscular dystrophy news →

Specialist Network

Top 6 by expertise

Luciano Merlini, MD

Istituto Ortopedico Rizzoli, Bologna, Italy

Score 101 trial

Steven A. Moore, M.D. Ph.D.

Co-Investigator

Score 31 trial

Katherine Mathews, M.D.

University of Iowa

Score 31 trial

Kevin Campbell, Ph.D.

Co-Investigator

Score 31 trial

Anne M Connolly, MD

Nationwide Childrens Hospital

Score 32 trials1 pub

Nicol Voermans

Radboud University Medical Center

Score 21 trial

View all Laminin subunit alpha 2-related muscular dystrophy specialists →

Quick Actions

📄

View Disease Page

Full profile, treatments, community

🔬

Search Clinical Trials

Find recruiting studies now

🩺

Find Specialists

Ranked by expertise & trials

💰

Financial Assistance

Copay cards, PAPs, grants

📰